Inositol is a sugar alcohol your body produces naturally, and it plays a key role in how cells respond to insulin and how certain brain chemicals function. As a supplement, it has the strongest evidence for improving insulin sensitivity, managing PCOS symptoms, supporting fertility, reducing panic attacks, and lowering the risk of gestational diabetes. Most research uses doses between 2 and 12 grams per day, depending on the condition.
How Inositol Works in Your Body
Inositol acts as a secondary messenger inside your cells, meaning it helps relay signals from hormones like insulin. When insulin binds to a cell, inositol-containing molecules are released that activate enzymes involved in processing blood sugar. These molecules essentially mimic some of insulin’s own effects, which is why supplementing with inositol can help when your body isn’t responding well to insulin on its own.
There are nine forms of inositol, but two matter most for supplementation: myo-inositol and D-chiro-inositol. Myo-inositol is the most abundant form in your body and the most widely studied. D-chiro-inositol plays a complementary role in how your body stores sugar. The two are often combined in supplements at a 40:1 ratio (typically 2 grams of myo-inositol plus 50 milligrams of D-chiro-inositol), which mirrors the natural ratio found in human blood plasma.
PCOS and Insulin Resistance
The most robust evidence for inositol supplementation comes from polycystic ovary syndrome. PCOS is closely tied to insulin resistance, and because inositol directly improves how cells respond to insulin, it addresses one of the condition’s root drivers rather than just managing symptoms. Clinical data shows it reduces blood sugar levels, lowers excess insulin, and buffers the downstream hormonal disruption that insulin resistance causes in the ovaries and endocrine system.
Myo-inositol has become a widely accepted treatment option for insulin-resistant PCOS, sometimes used as an alternative to hormonal therapies. Animal studies using the 40:1 myo-inositol to D-chiro-inositol ratio showed near-complete recovery from PCOS signs and symptoms, and clinical trials in women have confirmed these results. The benefits extend to more regular ovulation, improved hormone profiles, and better metabolic markers overall.
Fertility and Egg Quality
For women undergoing IVF, myo-inositol supplementation improves egg quality. A meta-analysis of 11 studies covering nearly 1,000 participants found that women taking myo-inositol had 55% higher odds of producing mature, fertilization-ready eggs compared to controls. The fertilization rate was also 62% higher in the supplementation group.
The benefits were especially pronounced for women with PCOS. In that subgroup, the odds of producing mature eggs nearly doubled, and fertilization rates improved significantly regardless of body weight. Women with poor ovarian response (a different fertility challenge unrelated to PCOS) did not see the same egg quality improvements, suggesting the benefit is tied to inositol’s insulin-sensitizing effects rather than a direct action on the ovaries.
Clinical pregnancy rates trended higher with supplementation but didn’t reach statistical significance across pooled studies. Individual trials reported pregnancy rates as high as 63% in PCOS patients using myo-inositol during IVF, though results varied.
Gestational Diabetes Prevention
Pregnant women at high risk for gestational diabetes may benefit substantially from myo-inositol. A meta-analysis of seven randomized controlled trials found that supplementation cut the risk of gestational diabetes by roughly 70%, with a relative risk of 0.3. The authors described the effect more conservatively as halving the risk, but the data consistently showed meaningful protection.
The effective protocol in these studies was 2 to 4 grams of myo-inositol daily, started around weeks 12 to 13 of pregnancy. “High risk” in these trials typically meant women with obesity, a family history of diabetes, or PCOS. The supplement also reduced complications associated with gestational diabetes, not just the diagnosis itself.
Panic Disorder and Depression
Inositol also influences brain signaling pathways, particularly those involving serotonin. A double-blind, placebo-controlled crossover trial gave 21 patients with panic disorder 12 grams of inositol per day for four weeks. Both the frequency and severity of panic attacks dropped significantly more during the inositol phase than during the placebo phase, and agoraphobia symptoms also improved.
The same research group had previously found inositol effective against depression in both open-label and controlled trials. The mechanism likely involves inositol’s role as a precursor to signaling molecules that brain cells use to respond to serotonin. At the 12-gram dose used in mental health research, inositol is well tolerated, though this is a much higher dose than what’s used for metabolic conditions.
Triglycerides and Metabolic Health
Beyond blood sugar, inositol supplementation has measurable effects on blood lipids. A systematic review and meta-analysis of randomized controlled trials in people with metabolic conditions found that inositol significantly reduced triglyceride levels. In postmenopausal women with metabolic syndrome specifically, supplementation improved systolic and diastolic blood pressure, insulin resistance, cholesterol, and triglycerides.
For body weight, a separate meta-analysis of randomized trials found that inositol supplementation reduced BMI by an average of 0.41 kg/m². That’s a modest effect in the general population, but it was more clinically meaningful in people who were already overweight or obese. The largest reductions appeared in overweight and obese women with PCOS, where BMI dropped by 0.78 kg/m² on average. Inositol isn’t a weight loss supplement in the traditional sense, but its metabolic effects can support modest body composition changes, particularly when insulin resistance is part of the picture.
Side Effects and Tolerability
Inositol is generally well tolerated, even at the higher doses used in mental health research. The most common side effects are gastrointestinal: diarrhea, nausea, and abdominal pain. Some people also report fatigue, headache, or dizziness. These tend to be mild and are more likely at higher doses.
In a head-to-head trial comparing myo-inositol to metformin (a common insulin-sensitizing medication) in women with PCOS, three participants dropped out of the metformin group due to intolerable gastrointestinal side effects over six months, while none left the inositol group for that reason. This tracks with inositol’s reputation as a gentler option for improving insulin sensitivity. Because it can lower blood sugar, anyone already taking blood sugar-lowering medications should be aware of the potential for an additive effect.